These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: Secukinumab may be remedy for systemic amyloidosis findings secondary to hidradenitis suppurativa.
    Author: Tas-Aygar G, Gonul M, Ozcan I, Ayli MD, Ertoy-Baydar D.
    Journal: Dermatol Ther; 2020 Nov; 33(6):e14205. PubMed ID: 32829493.
    Abstract:
    Hidradenitis suppurativa (HS) is a chronic relapsing inflammatory disease of follicular epithelium; many comorbidities occur that disrupt the quality of life of patients. Amyloidosis is one of them. We present a case with systemic amyloidosis secondary to HS and responding positively to secukinumab therapy. Secukinumab may also be an important option for amyloidosis findings in HS patients.
    [Abstract] [Full Text] [Related] [New Search]